当前位置:首页 - 行情中心 - 方盛制药(603998) - 财务分析 - 现金流量表

方盛制药

(603998)

  

流通市值:45.23亿  总市值:45.23亿
流通股本:4.39亿   总股本:4.39亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金946,185,261.3470,620,751.891,769,205,435.131,235,533,947.85
  收到的税费返还720,468.85-817,140.02824,405.67
  收到其他与经营活动有关的现金35,308,725.3114,475,375.8578,412,698.0666,449,232.19
  经营活动现金流入小计982,214,455.46485,096,127.741,848,435,273.211,302,807,585.71
  购买商品、接受劳务支付的现金122,280,793.6768,306,411.52345,996,554.54252,968,227.86
  支付给职工以及为职工支付的现金157,187,706.890,238,992.43279,890,063.37206,545,038.99
  支付的各项税费162,106,594.2880,968,479.2213,791,997.41143,270,208.3
  支付其他与经营活动有关的现金270,774,535.54165,396,191.6624,124,762.43475,147,864.82
  经营活动现金流出小计712,349,630.29404,910,074.751,463,803,377.751,077,931,339.97
  经营活动产生的现金流量净额269,864,825.1780,186,052.99384,631,895.46224,876,245.74
二、投资活动产生的现金流量:
  收回投资收到的现金464,946,637.95129,080,000794,744,724.59559,645,427.6
  取得投资收益收到的现金493,717.43138,096.35688,175.22443,534.59
  处置固定资产、无形资产和其他长期资产收回的现金净额4,244,489.38603,490.12,613,8711,923,020
  处置子公司及其他营业单位收到的现金净额--24,398,706.2624,398,706.26
  收到的其他与投资活动有关的现金11,075,0003,000,00076,789,05153,729,000
  投资活动现金流入小计480,759,844.76132,821,586.45899,234,528.07640,139,688.45
  购建固定资产、无形资产和其他长期资产支付的现金37,694,760.8322,141,722.18102,516,244.1163,509,679.01
  投资支付的现金519,080,000164,080,000715,000,000525,000,000
  支付其他与投资活动有关的现金10,564,993.5---
  投资活动现金流出小计567,339,754.33186,221,722.18817,516,244.11588,509,679.01
  投资活动产生的现金流量净额-86,579,909.57-53,400,135.7381,718,283.9651,630,009.44
三、筹资活动产生的现金流量:
  吸收投资收到的现金25,198,267.8811,065,37522,620,3369,080,000
  其中:子公司吸收少数股东投资收到的现金25,198,267.8811,065,37522,620,3369,080,000
  取得借款收到的现金269,000,000170,000,000363,400,000333,400,000
  筹资活动现金流入小计294,198,267.88181,065,375386,020,336342,480,000
  偿还债务支付的现金369,350,000195,000,000638,550,000508,750,000
  分配股利、利润或偿付利息支付的现金143,025,353.7568,358,906.36200,276,402.18197,375,585.2
  其中:子公司支付给少数股东的股利、利润7,006,500-7,006,5007,006,500
  支付其他与筹资活动有关的现金3,986,985.891,607,723.8241,304,984.3939,483,005.47
  筹资活动现金流出小计516,362,339.64264,966,630.18880,131,386.57745,608,590.67
  筹资活动产生的现金流量净额-222,164,071.76-83,901,255.18-494,111,050.57-403,128,590.67
四、汇率变动对现金及现金等价物的影响-64,825.9-23,830.36-90,882.9-16,775.9
五、现金及现金等价物净增加额-38,943,982.06-57,139,168.28-27,851,754.05-126,639,111.39
  加:期初现金及现金等价物余额268,170,278.7271,359,319.52296,022,032.75296,028,848.51
  期末现金及现金等价物余额229,226,296.64214,220,151.24268,170,278.7169,389,737.12
补充资料:
  净利润198,972,079.21-302,635,591.07-
  资产减值准备-136,219.03-9,768,205.7-
  固定资产和投资性房地产折旧31,483,179.95-60,018,412.6-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧31,483,179.95-60,018,412.6-
  无形资产摊销7,973,614.01-16,616,901.38-
  长期待摊费用摊销4,526,786.27-7,815,810.21-
  处置固定资产、无形资产和其他长期资产的损失---51,391,981.31-
  固定资产报废损失36,548.9-643,812.09-
  财务费用3,529,226.29-11,615,380.81-
  投资损失-21,857,068.2--1,688,667.73-
  递延所得税-612,812.19--2,590,015.73-
  其中:递延所得税资产减少898,412.57--1,119,216.66-
    递延所得税负债增加-1,511,224.76--1,470,799.07-
  存货的减少-17,704,497.52-32,289,097.86-
  经营性应收项目的减少-21,552,982.43--62,708,250.21-
  经营性应付项目的增加81,579,312.42-57,791,029.41-
  其他--175,229.28-
  现金的期末余额229,226,296.64-268,170,278.7-
  减:现金的期初余额268,170,278.7-296,022,032.75-
  现金及现金等价物的净增加额-38,943,982.06--27,851,754.05-
公告日期2026-08-292026-04-252026-04-252025-10-24
审计意见(境内)标准无保留意见
TOP↑